JP2025114800A5 - - Google Patents
Info
- Publication number
- JP2025114800A5 JP2025114800A5 JP2025080666A JP2025080666A JP2025114800A5 JP 2025114800 A5 JP2025114800 A5 JP 2025114800A5 JP 2025080666 A JP2025080666 A JP 2025080666A JP 2025080666 A JP2025080666 A JP 2025080666A JP 2025114800 A5 JP2025114800 A5 JP 2025114800A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- amount
- present
- citrate
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19174586 | 2019-05-15 | ||
| EP19174586.8 | 2019-05-15 | ||
| JP2021562843A JP7734587B2 (ja) | 2019-05-15 | 2020-05-14 | 皮膚エリテマトーデスの治療 |
| PCT/EP2020/063518 WO2020229622A1 (en) | 2019-05-15 | 2020-05-14 | Treatment of cutaneous lupus erythematosus |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562843A Division JP7734587B2 (ja) | 2019-05-15 | 2020-05-14 | 皮膚エリテマトーデスの治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025114800A JP2025114800A (ja) | 2025-08-05 |
| JP2025114800A5 true JP2025114800A5 (https=) | 2025-11-19 |
Family
ID=66554234
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562843A Active JP7734587B2 (ja) | 2019-05-15 | 2020-05-14 | 皮膚エリテマトーデスの治療 |
| JP2025080666A Pending JP2025114800A (ja) | 2019-05-15 | 2025-05-13 | 皮膚エリテマトーデスの治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562843A Active JP7734587B2 (ja) | 2019-05-15 | 2020-05-14 | 皮膚エリテマトーデスの治療 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20220241284A1 (https=) |
| EP (1) | EP3968997B1 (https=) |
| JP (2) | JP7734587B2 (https=) |
| KR (1) | KR20220008893A (https=) |
| CN (1) | CN113825512A (https=) |
| AU (1) | AU2020275208B2 (https=) |
| BR (1) | BR112021022031A2 (https=) |
| CA (1) | CA3137247A1 (https=) |
| IL (1) | IL288011A (https=) |
| MX (1) | MX2021012874A (https=) |
| SG (1) | SG11202110777XA (https=) |
| TW (1) | TWI863995B (https=) |
| UA (1) | UA129431C2 (https=) |
| WO (1) | WO2020229622A1 (https=) |
| ZA (1) | ZA202107300B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023202989A1 (en) | 2022-04-20 | 2023-10-26 | Leo Pharma A/S | Treatment of frontal fibrosing alopecia |
| WO2024194105A1 (en) * | 2023-03-17 | 2024-09-26 | Leo Pharma A/S | A method for the treatment of chronic hand eczema in patients with moderate to severe chronic hand eczema |
| WO2025085050A1 (en) * | 2023-10-16 | 2025-04-24 | Leo Pharma A/S | Treatment of frontal fibrosing alopecia |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1697342A2 (en) * | 2003-09-08 | 2006-09-06 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US20070264317A1 (en) * | 2006-05-15 | 2007-11-15 | Perrigo Israel Pharmaceuticals Ltd. | Imiquimod cream formulation |
| TWI466885B (zh) | 2009-07-31 | 2015-01-01 | Japan Tobacco Inc | 含氮螺環化合物及其醫藥用途 |
| US8883838B2 (en) * | 2010-12-03 | 2014-11-11 | Allergan, Inc. | Pharmaceutical cream compositions and methods of use |
| US20140343034A1 (en) | 2013-04-25 | 2014-11-20 | Japan Tobacco Inc. | Skin barrier function improving agent |
| WO2016112208A2 (en) * | 2015-01-09 | 2016-07-14 | Kineta One, Llp | Topical applications of kv1.3 channel blocking peptides to treat skin inflammation |
| PT3297605T (pt) * | 2015-05-21 | 2022-05-30 | Dermavant Sciences GmbH | Composições farmacêuticas tópicas |
| DK3405197T3 (da) * | 2016-01-21 | 2023-11-27 | Leo Pharma As | Topisk behandling af håndeksem |
-
2020
- 2020-05-14 KR KR1020217041029A patent/KR20220008893A/ko not_active Ceased
- 2020-05-14 EP EP20724533.3A patent/EP3968997B1/en active Active
- 2020-05-14 AU AU2020275208A patent/AU2020275208B2/en active Active
- 2020-05-14 JP JP2021562843A patent/JP7734587B2/ja active Active
- 2020-05-14 WO PCT/EP2020/063518 patent/WO2020229622A1/en not_active Ceased
- 2020-05-14 CA CA3137247A patent/CA3137247A1/en active Pending
- 2020-05-14 BR BR112021022031A patent/BR112021022031A2/pt unknown
- 2020-05-14 UA UAA202107241A patent/UA129431C2/uk unknown
- 2020-05-14 MX MX2021012874A patent/MX2021012874A/es unknown
- 2020-05-14 US US17/610,787 patent/US20220241284A1/en active Pending
- 2020-05-14 SG SG11202110777XA patent/SG11202110777XA/en unknown
- 2020-05-14 CN CN202080035580.1A patent/CN113825512A/zh active Pending
- 2020-05-15 TW TW109116313A patent/TWI863995B/zh active
-
2021
- 2021-09-28 ZA ZA2021/07300A patent/ZA202107300B/en unknown
- 2021-11-11 IL IL288011A patent/IL288011A/en unknown
-
2025
- 2025-05-13 JP JP2025080666A patent/JP2025114800A/ja active Pending
- 2025-11-11 US US19/385,693 patent/US20260069595A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025114800A5 (https=) | ||
| JP2008540532A5 (https=) | ||
| JP4674162B2 (ja) | アミノグリコシド系抗生物質およびブロムフェナクを含有する水溶液製剤 | |
| JP2023171614A5 (https=) | ||
| RU2011122629A (ru) | Водная композиция, содержащая фолликулостимулирующий гормон | |
| WO2010070705A1 (ja) | アムロジピンの安定な含水経口製剤 | |
| US12357655B2 (en) | Polyglutamic acid compositions and methods of using | |
| JP2024544538A5 (https=) | ||
| CN101854913A (zh) | 含有缬沙坦的液体组合物 | |
| JP6335269B2 (ja) | 医薬ソフトゼラチンカプセル剤形 | |
| JP2590156B2 (ja) | 経口投与用医薬組成物 | |
| JP2007501817A5 (https=) | ||
| JP2021520367A5 (https=) | ||
| ES2272092T3 (es) | Soluciones farmaceuticas que comprenden antiestrogenos de triofeniletileno. | |
| JPH02233613A (ja) | ピペリジノアルカノール誘導体類用の液体製剤組成物 | |
| JP5072748B2 (ja) | アムロジピンの安定な液剤とゼリー剤 | |
| ES2220138T3 (es) | Composiciones solubles de toremifeno. | |
| JP7733114B2 (ja) | ナラトリプタンを含む口腔内崩壊フィルム製剤 | |
| US4594359A (en) | Pharmaceutical compositions | |
| JP2023536938A5 (https=) | ||
| JP2024506291A5 (https=) | ||
| JP2024517801A5 (https=) | ||
| HUT63060A (en) | Process for producing pharmaceutical compositions locally applicable on nose and eye, comprising bradykinin antagonists | |
| TWI677346B (zh) | 含有多肽之醫藥組成物 | |
| FI81257B (fi) | Foerfarande foer framstaellning av en vattenbaserad farmaceutisk blandning. |